UB Paderborn / Katalog / Suche / in CDI

1 – 14 von 14

Sortiert nach

MicroRNAs dysregulated in multiple sclerosis affect the differentiation of CG-4 cells, an oligodendrocyte progenitor cell line

Frontiers in cellular neuroscience, 2024-02, Vol.18, p.1336439-1336439

2024

Volltextzugriff (PDF)

N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation

Biochimica et biophysica acta. Molecular and cell biology of lipids, 2017-05, Vol.1862 (5), p.474-484

2017

Volltextzugriff (PDF)

25‐Hydroxycholesterol metabolism is altered by lung inflammation, and its local administration modulates lung inflammation in mice

The FASEB journal, 2021-04, Vol.35 (4), p.e21514-e21514

2021

Volltextzugriff (PDF)

miRNA profile is altered in a modified EAE mouse model of multiple sclerosis featuring cortical lesions

eLife, 2020-09, Vol.9

2020

Volltextzugriff (PDF)

Influence of a pro-inflammatory stimulus on the miRNA and lipid content of human dental stem cell-derived extracellular vesicles and their impact on microglial activation

Heliyon, 2024-03, Vol.10 (5), p.e27025-e27025, Article e27025

2024

Volltextzugriff (PDF)

N-acylethanolamine hydrolyzing acid amidase inhibition: tools and potential therapeutic opportunities

Drug discovery today, 2018-08, Vol.23 (8), p.1520-1529

2018

Volltextzugriff (PDF)

25‐Hydroxycholesterol metabolism is altered by lung inflammation, and its local administration modulates lung inflammation in mice

The FASEB journal, 2021-04, Vol.35 (4), p.e21514-n/a

2021

Volltextzugriff (PDF)

The α/β–hydrolase domain 6 inhibitor WWL70 decreases endotoxin‐induced lung inflammation in mice, potential contribution of 2‐arachidonoylglycerol, and lysoglycerophospholipids

The FASEB journal, 2019-06, Vol.33 (6), p.7635-7646

2019

Volltextzugriff (PDF)

Lysophosphatidylinositols in inflammation and macrophage activation: Altered levels and anti-inflammatory effects

Biochimica et biophysica acta. Molecular and cell biology of lipids, 2018-12, Vol.1863 (12), p.1458-1468

2018

Volltextzugriff (PDF)

Lipid nanocapsules for the nose-to-brain delivery of the anti-inflammatory bioactive lipid PGD2-G

Nanomedicine, 2023-02, Vol.48, p.102633-102633, Article 102633

2023

Volltextzugriff (PDF)

N‐Acylethanolamine‐hydrolyzing acid amidase inhibition increases colon N‐palmitoylethanolamine levels and counteracts murine colitis

The FASEB journal, 2015-02, Vol.29 (2), p.650-661

2015

Volltextzugriff (PDF)

Lipid nanocapsules for the nose-to-brain delivery of the anti-inflammatory bioactive lipid PGD 2 -G

Nanomedicine, 2023-02, Vol.48, p.102633

2023

Volltextzugriff (PDF)

Abstract 4863: PF-06840003: a highly selective IDO-1 inhibitor that shows good in vivo efficacy in combination with immune checkpoint inhibitors

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4863-4863

2016

Volltextzugriff (PDF)

1 – 14 von 14

Suche als RSS-Feed

Aktive Filter

ThemaBiomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(14)

Sprache

Englisch
(14)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(11)
Life Sciences & Biomedicine
(10)
Animals
(5)
Biochemistry & Molecular Biology
(5)
Cell Biology
(5)
Mice
(5)
Biology
(4)
Life Sciences & Biomedicine - Other Topics
(4)
Multiple Sclerosis
(3)
Amidohydrolases - Metabolism
(2)
Anti-Inflammatory Agents - Pharmacology
(2)
Arachidonic Acids - Metabolism
(2)
Ards
(2)
Biophysics
(2)
Corticosteroid
(2)
Cytokines
(2)
Endocannabinoids - Metabolism
(2)
Ethanolamines - Metabolism
(2)
Female
(2)
Humans
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

MicroRNAs dysregulated in multiple sclerosis affect the differentiation of CG-4 cells, an oligodendrocyte progenitor cell line

Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3‑(5-Fluoro‑1H‑indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate

N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation

25‐Hydroxycholesterol metabolism is altered by lung inflammation, and its local administration modulates lung inflammation in mice

miRNA profile is altered in a modified EAE mouse model of multiple sclerosis featuring cortical lesions

Influence of a pro-inflammatory stimulus on the miRNA and lipid content of human dental stem cell-derived extracellular vesicles and their impact on microglial activation

N-acylethanolamine hydrolyzing acid amidase inhibition: tools and potential therapeutic opportunities

25‐Hydroxycholesterol metabolism is altered by lung inflammation, and its local administration modulates lung inflammation in mice

The α/β–hydrolase domain 6 inhibitor WWL70 decreases endotoxin‐induced lung inflammation in mice, potential contribution of 2‐arachidonoylglycerol, and lysoglycerophospholipids

Lysophosphatidylinositols in inflammation and macrophage activation: Altered levels and anti-inflammatory effects

Lipid nanocapsules for the nose-to-brain delivery of the anti-inflammatory bioactive lipid PGD2-G

N‐Acylethanolamine‐hydrolyzing acid amidase inhibition increases colon N‐palmitoylethanolamine levels and counteracts murine colitis

Lipid nanocapsules for the nose-to-brain delivery of the anti-inflammatory bioactive lipid PGD 2 -G

Abstract 4863: PF-06840003: a highly selective IDO-1 inhibitor that shows good in vivo efficacy in combination with immune checkpoint inhibitors

Aktive Filter

Suchergebnisse filtern